{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T02:02:25Z","timestamp":1792202545398,"version":"4.4.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.hlc.2022.09.004","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T10:07:26Z","timestamp":1665396446000},"page":"1630-1639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Long-Term Ambulatory Intravenous Milrinone Therapy in Advanced Heart Failure"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-927X","authenticated-orcid":false,"given":"Sandipan","family":"Shringi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiksha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Suffredini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6649-8273","authenticated-orcid":false,"given":"Ashley","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8502-3628","authenticated-orcid":false,"given":"Navin","family":"Rajagopalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Guglin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2022.09.004_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.09.004_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2010.165","article-title":"Epidemiology and risk profile of heart failure","volume":"8","author":"Bui","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.hlc.2022.09.004_bib3","first-page":"e38","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.09.004_bib4","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1161\/CIR.0b013e31824f2173","article-title":"Decision making in advanced heart failure: a scientific statement from\u00a0the American Heart Association","volume":"125","author":"Allen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.09.004_bib5","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1161\/hc4901.102568","volume":"104","author":"Hunt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2022.09.004_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0002-8703(97)80012-9","article-title":"Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy","volume":"134","author":"Sindone","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2022.09.004_bib7","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1378\/chest.112.5.1298","article-title":"Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes","volume":"112","author":"Harjai","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.09.004_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4212\/cjhp.v64i4.1061","article-title":"Home inotrope program for patients with end-stage heart failure awaiting heart transplant","volume":"64","author":"Chua","year":"2011","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.hlc.2022.09.004_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2022.09.004_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijcard.2020.04.055","article-title":"Long-term milrinone therapy as a bridge to heart transplantation: safety, efficacy, and predictors of failure","volume":"313","author":"Lee","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2022.09.004_bib11","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1053-2498(03)00203-1","article-title":"Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure","volume":"23","author":"Upadya","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2022.09.004_bib12","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S0002-8703(96)90315-4","article-title":"Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure","volume":"132","author":"Marius-Nunez","year":"1996","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2022.09.004_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1161\/CIRCHEARTFAILURE.108.839076","article-title":"Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure","volume":"2","author":"Gorodeski","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hlc.2022.09.004_bib14","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1054\/jcaf.2003.24","article-title":"Care processes and clinical outcomes of continuous outpatient support with inotropes (COSI) in patients with refractory endstage heart failure","volume":"9","author":"Hershberger","year":"2003","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.hlc.2022.09.004_bib15","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S1053-2498(03)00203-1","article-title":"Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure","volume":"23","author":"Upadya","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2022.09.004_bib16","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1378\/chest.112.5.1298","article-title":"Home inotropic therapy in advanced heart failure","volume":"112","author":"Harjai","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2022.09.004_bib17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjcard.2015.12.030","article-title":"Infections, arrhythmias, and hospitalizations on home intravenous inotropic therapy","volume":"117","author":"Acharya","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2022.09.004_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.08.003","article-title":"Chronic inotropic therapy in end-stage heart failure","volume":"152","author":"Hauptman","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2022.09.004_bib19","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.healun.2003.08.017","article-title":"A\u00a0prospective study of continuous intravenous milrinone therapy for status IB patients awaiting heart transplant at home","volume":"23","author":"Brozena","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.hlc.2022.09.004_bib20","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.mayocpiqo.2020.05.007","article-title":"Expected vs actual outcomes of elective initiation of inotropic therapy during heart failure hospitalization","volume":"4","author":"Snipelisky","year":"2020","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/j.hlc.2022.09.004_bib21","article-title":"Survival with continuous outpatient intravenous inotrope therapy in the modern era","author":"Mody","year":"2020","journal-title":"Am J Ther"},{"key":"10.1016\/j.hlc.2022.09.004_bib22","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.amjmed.2019.11.023","article-title":"Safety of outpatient milrinone infusion in end-stage heart failure: ICD-level data on atrial fibrillation and ventricular tachyarrhythmias","volume":"133","author":"Harhash","year":"2020","journal-title":"Am J Med"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622010976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950622010976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:07:34Z","timestamp":1761415654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950622010976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1443950622010976"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2022.09.004","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Ambulatory Intravenous Milrinone Therapy in Advanced Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2022.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}